HTAC recommendation on the minor inclusion of potassium citrate [1620 mg (15mEq)] tablet in the PNF HTAC recommendation on the inclusion of Tocilizumab in the PNF SECRETARY OF HEALTH APPROVAL OF THE HTAC RECOMMENDATION ON FOURTH DOSE FOR IMMUNOCOMPROMISED POPULATIONS (ICPs) HTAC recommendation on the reinclusion of vasopressin in the PNF Pediatric Vaccination for the prevention of COVID-19 for 5 to 11 age group GABAY NG HTAC: PAGSAMA NG ORAL PREP SA PNF HTAC GUIDANCE: Oral PrEP for inclusion in the PNF HTAC recommendation on the minor inclusion of sambong 250mg tablet for anti-urolithiasis (kidney stones) in the Philippine National Formulary (PNF) HTAC interim recommendation on the use of casirivimab+imdevimab for the treatment of COVID-19 HTAC Recommendation: COVID-19 Vaccine Sputnik V Posts navigation 123 Older Older
SECRETARY OF HEALTH APPROVAL OF THE HTAC RECOMMENDATION ON FOURTH DOSE FOR IMMUNOCOMPROMISED POPULATIONS (ICPs)
HTAC recommendation on the minor inclusion of sambong 250mg tablet for anti-urolithiasis (kidney stones) in the Philippine National Formulary (PNF)